Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Pietrobono

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Cellular and Molecular Gastroenterology and Hepatology|June 28, 2021
A Novel atTAK Against Hepatocellular Carcinoma: Overcoming Resistance to SorafenibSilvia Pietrobono, Davide Melisi
Cells|December 19, 2018
Targeting the Oncoprotein Smoothened by Small Molecules: Focus on Novel Acylguanidine Derivatives as Potent Smoothened InhibitorsSilvia Pietrobono, Barbara Stecca
Oncotarget|May 26, 2023
Combined targeting of HEDGEHOG signaling and BRD4 as a novel therapeutic option against melanomaSilvia Pietrobono, Barbara Stecca
Cancers|April 30, 2021
Aberrant Sialylation in Cancer: Biomarker and Potential Target for Therapeutic Intervention?Silvia Pietrobono, Barbara Stecca
Frontiers in Genetics|June 28, 2019
Non-canonical Hedgehog Signaling Pathway in Cancer: Activation of GLI Transcription Factors Beyond SmoothenedSilvia Pietrobono, Sinforosa Gagliardi, Barbara Stecca
Cells|August 27, 2021
The Role of Glycosylation in Melanoma ProgressionChiara De Vellis, Silvia Pietrobono, Barbara Stecca
Frontiers in Oncology|November 13, 2018
Soft Tissue Sarcoma Cancer Stem Cells: An OverviewKatia C Genadry, Silvia Pietrobono, Rossella Rota, et al.
Plos One|March 25, 2015
Splice variants of activation induced deaminase (AID) do not affect the efficiency of class switch recombination in murine CH12F3 cellsCesare Sala, Giorgio Mattiuz, Silvia Pietrobono, et al.
Cancers|October 13, 2021
MAPK15 Controls Hedgehog Signaling in Medulloblastoma Cells by Regulating Primary CiliogenesisSilvia Pietrobono, Lorenzo Franci, Francesco Imperatore, et al.
Therapeutic Advances in Medical Oncology|April 8, 2024
Integration of liposomal irinotecan in the first-line treatment of metastatic pancreatic cancer: try to do not think about the white bearDavide Melisi, Simona Casalino, Silvia Pietrobono, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Cellular and Molecular Gastroenterology and Hepatology|June 28, 2021
A Novel atTAK Against Hepatocellular Carcinoma: Overcoming Resistance to SorafenibSilvia Pietrobono, Davide Melisi
Cells|December 19, 2018
Targeting the Oncoprotein Smoothened by Small Molecules: Focus on Novel Acylguanidine Derivatives as Potent Smoothened InhibitorsSilvia Pietrobono, Barbara Stecca
Oncotarget|May 26, 2023
Combined targeting of HEDGEHOG signaling and BRD4 as a novel therapeutic option against melanomaSilvia Pietrobono, Barbara Stecca
Cancers|April 30, 2021
Aberrant Sialylation in Cancer: Biomarker and Potential Target for Therapeutic Intervention?Silvia Pietrobono, Barbara Stecca
Frontiers in Genetics|June 28, 2019
Non-canonical Hedgehog Signaling Pathway in Cancer: Activation of GLI Transcription Factors Beyond SmoothenedSilvia Pietrobono, Sinforosa Gagliardi, Barbara Stecca
Cells|August 27, 2021
The Role of Glycosylation in Melanoma ProgressionChiara De Vellis, Silvia Pietrobono, Barbara Stecca
Frontiers in Oncology|November 13, 2018
Soft Tissue Sarcoma Cancer Stem Cells: An OverviewKatia C Genadry, Silvia Pietrobono, Rossella Rota, et al.
Plos One|March 25, 2015
Splice variants of activation induced deaminase (AID) do not affect the efficiency of class switch recombination in murine CH12F3 cellsCesare Sala, Giorgio Mattiuz, Silvia Pietrobono, et al.
Cancers|October 13, 2021
MAPK15 Controls Hedgehog Signaling in Medulloblastoma Cells by Regulating Primary CiliogenesisSilvia Pietrobono, Lorenzo Franci, Francesco Imperatore, et al.
Therapeutic Advances in Medical Oncology|April 8, 2024
Integration of liposomal irinotecan in the first-line treatment of metastatic pancreatic cancer: try to do not think about the white bearDavide Melisi, Simona Casalino, Silvia Pietrobono, et al.
Pageof 3